Severe allergic reaction (eg, anaphylaxis) after a previous dose of any diphtheria toxoid-, tetanus toxoid-, pertussis-, hepatitis B-, or poliovirus-containing vaccine or to any component of PEDIARIX is a contraindication for PEDIARIX

...continue reading

  • KINRIX is available in:
    • 0.5-mL single-dose vials
    • 0.5-mL single-dose prefilled Tip-Lok® syringes (packaged without needles)
  • KINRIX is to be administered as a 0.5-mL dose by intramuscular injection
    • The preferred site of administration is the deltoid muscle of the upper arm
  • KINRIX may be used for the fifth dose in the DTaP immunization series and the fourth dose in the IPV immunization series in children 4 through 6 years of age (prior to the seventh birthday) whose previous DTaP vaccine doses have been with INFANRIX and/or PEDIARIX for the first three doses and INFANRIX for the fourth dose
  • Sufficient data on the safety and effectiveness of interchanging PEDIARIX, INFANRIX, and KINRIX with DTaP-containing vaccines from different manufacturers are not available
  • CPT® code: 90696 "scrollbars=yes, resizable=yes, width=400, height=400,top=500, left=500"[5]

The tip caps of the prefilled syringes contain natural rubber latex, which may cause allergic reactions.

Store refrigerated between 2° and 8°C (36° and 46°F).
Do not freeze. Discard if the vaccine has been frozen.

INFANRIX, KINRIX, PEDIARIX, and Tip-Lok are registered trademarks of the GSK group of companies.

Luer-Lok is a registered trademark of Becton, Dickinson and Company.

CPT is a registered trademark of the American Medical Association.

References

"scrollbars=yes, resizable=yes, width=400, height=400,top=500, left=500" View all references

814573R0 January 2017